Mellowmood77 Tuesday, 09/17/19 03:53:30 PM Re: north40000 post# 214829 Post # of 220596 Completely de-risked with patent litigation and FDA approval the simple answer is yes. Over 200 million statin users world wide. If only 1/5 of them get on V we are talking 64 billion in annual revenue. A company like GILD would be able to get there much faster as well. If we get a wider than expected label from the FDA.... (stand-alone option) all bets are off.